Planet Labs PBC (PL) Ships Pelican-3 and Pelican-4 Satellites to Vandenberg

Following the shipment announcement of Pelican-3 and Pelican-4 satellites to Vandenberg Space Force Base on July 29, 2025, Planet Labs PBC (PL) experienced a 77% increase in share price over the last quarter. This substantial price move might be associated with the company's robust operational updates, including deployed over 650 Earth observation satellites and its plan to launch additional Pelican satellites. This progress coincides with broader market optimism fueled by potential Federal Reserve rate cuts as signaled by Jerome Powell. While Planet Labs's developments contributed positively, recent market stability added more weight to the stock's momentum.

We've identified 2 warning signs with Planet Labs PBC and understanding the impact should be part of your investment process.

The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

The recent shipment of Pelican-3 and Pelican-4 satellites signifies a major advancement in Planet Labs PBC’s operational capabilities, potentially influencing revenue and earnings forecasts. This expansion could drive cash flow positivity with strategic partnerships and further enhance net margins. The 77% share price increase over the last quarter reflects optimism surrounding these developments, with a fair degree of momentum carried by the broader market dynamics such as potential Federal Reserve rate cuts. Analysts have set a consensus price target of US$7.16, which is only slightly above the current share price of US$7.06, indicating a perception of fair valuation for the period.

For a longer-term context, over the past year, Planet Labs’ total return, including both share price movements and dividends, surged by a very large 173.64%. This performance significantly exceeded the US market's 15.5% return and outpaced the US Professional Services industry's 2.2% return over the same period. While revenues are forecast to grow at 17.1% annually, the expected persisting unprofitability presents a challenge to their narrative of financial stability and growth. Analysts continue to foresee potential earnings improvements if execution on high-value solutions and partnerships progresses effectively.

According our valuation report, there's an indication that Planet Labs PBC's share price might be on the expensive side.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com